Literature DB >> 16650632

The risk of aprotinin: a conflict of evidence.

Artyom Sedrakyan1, David Atkins, Tom Treasure.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16650632     DOI： 10.1016/S0140-6736(06)68590-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Antifibrinolytic therapy: evidence, bias, confounding (and politics!).

Authors:  Paul Myles
Journal:  J Extra Corpor Technol       Date:  2007-12

2.  Effects of opium addiction on bleeding after coronary artery bypass graft surgery: report from Iran.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh; Gholamreza Safaee Ardekani
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-09-22

3.  The impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgery.

Authors:  Alain Vuylsteke; Palanikumar Saravanan; Caroline Gerrard; Fay Cafferty
Journal:  BMC Anesthesiol       Date:  2006-08-30       Impact factor: 2.217

4.  Patients' and therapists' experiences with a new treatment programme for eating disorders that combines physical exercise and dietary therapy: the PED-t trial. A qualitative study protocol.

Authors:  Gunn Pettersen; Jan H Rosenvinge; Maria Bakland; Rolf Wynn; Therese Fostervold Mathisen; Jorunn Sundgot-Borgen
Journal:  BMJ Open       Date:  2018-01-08       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.